Search

everythinglearnresearchcommunity

for

Search:↓

Not all nail problems are caused by fungus, new allergens are being identified, PCOS has various treatments, and aesthetic procedures like Botox are advancing.

Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.

Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Tofacitinib may help treat severe hair loss, but more research is needed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Stem cells from hair follicles can safely treat hair loss.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Baricitinib is effective and safe for treating severe alopecia areata.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Multiple treatments work best for hair loss.

Oral minoxidil and topical minoxidil 5% both effectively improve female-pattern hair loss with safe side effects.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Men with Kennedy disease have less chance of hair loss.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Ginsenoside Rb1 from Panax ginseng helps mink hair grow by activating certain cell signals.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.